Please feel free forward to your colleagues and share the news of our journal | Announcing: Special Issue | Volume 8, Issue 5 Guest Editors: Annemieke Aartsma-Rus and Virginia Arechavala-Gomeza | Extract of the editorial by the guest editors: "It is clear that results that prove an original hypothesis to be incorrect advance knowledge as much as those that confirm it. Still, in the era of 'publish or perish' results that disprove the hypothesis tested are not published at the rate that should be expected, and the lack of reproducibility has also been recently highlighted as a problem that needs to be addressed. A publication bias towards therapeutic approaches that appear to have beneficial effects and lack of published studies where therapies are either not useful or toxic, or where published results are not reproducible, not only impedes science and therapy development. It also leads to unnecessary duplication of efforts and a waste of resources. In any field this is not optimal, but in a rare disease field – such as research in neuromuscular disorders – this is a tragedy. In light of this, we are happy to present a whole issue dedicated to well-executed research that obtained what many may consider 'negative' results." | EDITORIAL Sharing “Negative” Results in Neuromuscular Research: A Positive Experience – Openly Available Arechavala-Gomeza, Virginia | Aartsma-Rus, Annemieke RESEARCH ARTICLES A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial – Open Access Finkel, Richard S. | McDonald, Craig M. | Lee Sweeney, H. | Finanger, Erika | Neil Knierbein, Erin | Wagner, Kathryn R. | Mathews, Katherine D. | Marks, Warren | et al. Minimal Consequences of CMAH and DBA/2 Backgrounds on a FKRP Deficient Model Vaubourg, Camille | Gicquel, Evelyne | Richard, Isabelle | Lostal, William | Bellec, Jessica Plasma Creatinine Level Does Not Predict Respiratory Function in Amyotrophic Lateral Sclerosis Morgadinho, João | Pronto-Laborinho, Ana Catarina | Conceição, Vasco A. | Gromicho, Marta | Pinto, Susana | Swash, Michael | de Carvalho, Mamede Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies Greco, Anna | Straasheijm, Kirsten R. | Mul, Karlien | van den Heuvel, Anita | van der Maarel, Silvère M. | Joosten, Leo A.B. | van Engelen, Baziel G.M. | Pruijn, Ger J.M. Electrostatic Coating of Viral Particles for Gene Delivery Applications in Muscular Dystrophies: Influence of Size on Stability and Antibody Protection Guerra-Rebollo, Marta | Stampa, María | Lázaro, Miguel Ángel | Cascante, Anna | Fornaguera, Cristina | Borrós, Salvador Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia Gravis Sinaei, Farnaz | Fatehi, Farzad | Oveis Gharan, Shahram | Ehsan, Soroush | Kamali, Koorosh | Amirzargar, Aliakbar | Mahmoudi, Mahdi | Vaghefifar, Alaleh | Nafissi, Shahriar The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis Odierna, Gianmaria Lorenzo | Phillips, William Donald Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy – Open Access Verhaart, Ingrid E.C. | Cappellari, Ornella | Tanganyika-de Winter, Christa L. | Plomp, Jaap J. | Nnorom, Sofia | Wells, Kim E. | Hildyard, John C.W. | Bull, David | et al. LETTERS Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020 – Openly Available Whitehead, N.P. | Kim, M.J. | Bible, K.L | Adams, M.E. | Froehner, S.C. Author’s Response to: Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020 – Openly Available Aartsma-Rus, Annemieke | Verhaart, Ingrid | Wells, Dominic | TREAT-NMD News TREAT-NMD is organising the 7th international conference focusing on translational medicine in inherited neuromuscular diseases to be held from June 15–17, 2022 in Vancouver in Canada. The aim of this international conference will be to share progress and lessons learned in the area of translational medicine in inherited neuromuscular diseases and plan for the delivery of future therapies to patients. More details will be available via the conference website in due course. | Most Read JND Articles in August 2021 Listing articles published only in 2020 and 2021 so you can read the most popular recent content Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report – Open Access (Research Article in pre-press, 2021) Molera, Cristina | Sarishvili, Tinatin | Nascimento, Andrés | Rtskhiladze, Irakli | Muñoz Bartolo, Gema | Fernández Cebrián, Santiago | Valverde Fernández, Justo | et al. Molecular Mechanisms of Skeletal Muscle Hypertrophy – Open Access (Review Article in Vol.8, Iss.2, 2021) Schiaffino, Stefano | Reggiani, Carlo | Akimoto, Takayuki | Blaauw, Bert A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment – Open Access (Research Article in pre-press, 2021) Mitelman, Olga | Abdel-Hamid, Hoda Z. | Byrne, Barry J. | Connolly, Anne M. | Heydemann, Peter | Proud, Crystal | Shieh, Perry B. | Wagner, Kathryn R. | et al. Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial – Open Access (Research Article in pre-press, 2021) McDonald, Craig M. | Shieh, Perry B. | Abdel-Hamid, Hoda Z. | Connolly, Anne M. | Ciafaloni, Emma | Wagner, Kathryn R. | Goemans, Nathalie | Mercuri, Eugenio | et al. Current View of Diagnosing Small Fiber Neuropathy – Open Access (Review Article in Vol.8, Iss.2, 2021) Raasing, Lisette R.M. | Vogels, Oscar J.M. | Veltkamp, Marcel | van Swol, Christiaan F.P. | Grutters, Jan C. Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for Care – Open Access (Review Article in Vol.7, Iss.1, 2020) Schorling, David C. | Pechmann, Astrid | Kirschner, Janbernd | Sign Ups & Social Media Help Spread the News of JND! If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the sign-up link at the bottom of this email or access here. If you are not yet interacting with JND on social media, why not take the time today to follow us on Twitter and find us on Facebook? Be part of the discussion! | Indexed in: PubMed/MEDLINE Scopus | Submit your Paper As a member of our research community, we would like to invite you to contribute your own articles to the journal. JND offers contributing authors many benefits, including rigorous peer review and speedy manuscript processing, rapid online publication (pre-press) and an affordable open access option (€1250/US$1450). JND is fully compliant with all mandates by major funders, and open access articles are automatically uploaded to PubMed Central. More reasons to publish in JND are outlined on the journal's website! Submit your manuscript online via MsTracker View detailed Instructions to Authors Aims and Scope | You are receiving this mailing as you are signed up to receive news from JND. You can unsubscibe or alter your preferences at any time by clicking the links below. | |